Bone Tissue Engineering: From Biomaterials to Clinical Trials
Advances in experimental medicine and biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Enhancing the clinical translation of stem cell models by focusing on standardization and international regulatory cooperation
Wei Wang,
No information about this author
Anran Song,
No information about this author
Hong‐Wen Liu
No information about this author
et al.
World Journal of Stem Cells,
Journal Year:
2025,
Volume and Issue:
17(4)
Published: April 21, 2025
The
article
by
Granjeiro
et
al
provided
a
thorough
review
of
the
role
stem
cell
models
in
development
advanced
therapy
medicinal
products.
It
emphasized
potential
to
refine
preclinical
studies
and
align
with
regulatory
requirements
for
clinical
applications.
This
introduced
new
perspective
on
enhancing
transition
research
into
practice,
focusing
importance
international
harmonization
need
standardization
cell-based
therapies.
Language: Английский
Advancements in 3D Cell Culture Models for Drug Discovery and Disease Modeling
Next frontier.,
Journal Year:
2024,
Volume and Issue:
8(1), P. 203 - 203
Published: Nov. 28, 2024
The
advent
of
3D
cell
culture
models
has
revolutionized
drug
discovery
and
disease
modeling,
offering
more
physiologically
relevant
systems
compared
to
traditional
2D
cultures.
These
advanced
mimic
the
in
vivo
microenvironment,
incorporating
critical
cellular
interactions,
extracellular
matrix
components,
gradients
oxygen
nutrients.
This
research
explores
development
application
technologies,
such
as
organoids,
spheroids,
bioprinted
tissues,
studying
mechanisms
evaluating
efficacy.
study
highlights
advantages
these
recapitulating
complex
biological
processes,
including
tumor
microenvironments,
organ
development,
tissue-specific
responses
therapeutic
agents.
By
employing
cutting-edge
techniques
microfluidics,
imaging,
computational
aims
optimize
for
high-throughput
screening
personalized
medicine.
findings
underscore
transformative
potential
bridging
gap
between
preclinical
studies
clinical
outcomes,
reducing
costs
improving
patient-specific
approaches.
Language: Английский